RDY DR REDDYS LABORATORIES LTD

NEUTRAL Impact: 2/10 6-K
Horizon months Filed May 11, 2026 Processed 9d 23h ago SEC 0001575872-26-000280
Notable filing: 6-K
Latest settled — T+5d ⚠ clustered
RDY ▲ +3.50% at T+5d
NEUTRAL call ✓ call won +3.50% · α vs SPY +3.59% · entry $13.14 → $13.60
Next anchor: T+20d in 19d
Currently $13.47 · +2.47% from $13.14 entry
Entry anchored
May 11, 12:47 PM ET
via Databento tick
T+1d
-5.17%
call -5.17% · α -5.04%
$12.46
settled 9d ago
T+5d
+3.50%
call +3.50% · α +3.59%
$13.60
settled 3d ago
T+20d
call — · α —
in 19d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

Dr. Reddy's granted 1,192,234 stock options (816,119 Indian stock options + 376,115 ADR stock options) to eligible employees under existing ESOP schemes at an exercise price of Rs. 1,293.90 per share. This is a routine employee compensation event with no material financial impact or strategic significance.

Actionable Insight

Routine ESOP grant with no immediate trading implications. Monitor next quarterly filing for potential modest dilution impact from option exercises, though 3-year vesting makes this a distant consideration.

Key Facts

  • Grant of 816,119 Indian stock options under Dr. Reddy's Employees Stock Option Scheme, 2018
  • Grant of 376,115 ADR stock options under Dr. Reddy's Employees ADR Stock Option Scheme, 2007
  • Exercise price of Rs. 1,293.90 per share for both tranches
  • 100% vesting at the end of 3 years for both option types
  • Approved by Nomination, Governance and Compensation Committee on May 11, 2026

Financial Impact

No material financial impact — standard employee stock compensation grant with 3-year vesting; dilution is minimal relative to total shares outstanding

dilution

Risk Factors

  • Minimal dilution risk from eventual option exercises over 3-year vesting period

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
50% bullish (44 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001575872-26-000280
Document: 0001575872-26-000280-index.html0001575872-26-000280
Document: 0001575872-26-000280.txt0001575872-26-000280
15 reports for RDY
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for RDY — sortable, filterable
Type Now
May 18, 2026
2d ago
6-K
NEUTRAL ★ 2/10
$13.57 awaiting T+5awaiting T+5$13.47 (−0.74%)
May 18, 2026
3d ago
6-K
NEUTRAL ★ 2/10
awaiting T+5
May 15, 2026
5d ago
6-K
BULLISH ★ 6/10
$13.62 awaiting T+5awaiting T+5$13.47 (−1.10%)
May 12, 2026
8d ago
6-K
NEUTRAL ★ 3/10
$12.99 $13.45▲ +3.54%▲ +4.70%$13.47 (+3.66%)
May 12, 2026
8d ago
6-K
NEUTRAL ★ 2/10
$12.46 $13.60▲ +9.15%▲ +9.07%$13.47 (+8.07%)
May 12, 2026
9d ago
6-K
NEUTRAL ★ 2/10
$12.46 $13.60▲ +9.15%▲ +9.07%$13.47 (+8.07%)
May 12, 2026
9d ago
6-K
NEUTRAL ★ 1/10
$12.46 $13.60▲ +9.15%▲ +9.07%$13.47 (+8.07%)
May 11, 2026
9d ago
6-K
NEUTRAL ★ 2/10
$13.14 $13.60▲ +3.50%▲ +3.59%$13.47 (+2.47%)
Apr 29, 2026
22d ago
6-K
BULLISH ★ 6/10
awaiting T+5
Apr 24, 2026
27d ago
6-K
NEUTRAL ★ 3/10
$13.67 $13.64▼ −0.22%▼ −1.13%$13.47 (−1.50%)
Showing 10 of 15

US Market Status

Market Open — Closes in 3h 53m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access